
What if the Media Reported on Prescription Drugs Like They Do on Cannabis?
The New York Times’ recent cannabis coverage leans on cherry-picked data and fear-driven narratives—here’s why that matters. This is a cross-post from the Doctor Approved Cannabis substack by Dr. Benjamin Caplan, MD. More information below the article. Last week, the New York Time’s flagship podcast, The Daily,